Two analytical techniques do almost all of the work behind a credible peptide Certificate of Analysis: High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). They answer different questions — HPLC measures how pure a sample is, MS confirms what the molecule actually is — and together they form the evidentiary basis for any purity or identity claim on a research peptide label. This article explains how each method works.
HPLC: Separating and Quantifying
High-Performance Liquid Chromatography works by forcing a liquid sample, under high pressure, through a column packed with a solid stationary phase. Different components of the sample interact with that stationary phase to different degrees, so they travel through the column at different speeds and exit ("elute") at different times. A detector — most commonly a UV absorbance detector tuned to a wavelength peptides absorb strongly, around 214–220 nm — records each eluting component as a peak on a chromatogram.
For peptide purity testing, the relevant setup is almost always reversed-phase HPLC (RP-HPLC), where the column's stationary phase is nonpolar (commonly a C18-bonded silica) and the mobile phase is a polar solvent gradient, typically water and acetonitrile with a small amount of trifluoroacetic acid (TFA) as an ion-pairing agent. Under this setup, the target peptide elutes as the dominant peak, while truncated sequences, deletion products, or oxidized variants from the synthesis process appear as smaller, separate peaks.
Purity is calculated as the area under the main peak divided by the total area under all peaks, expressed as a percentage. This is why a single purity number is only meaningful alongside the underlying chromatogram: a 99% figure next to a clean, single sharp peak means something different from a 99% figure that was calculated after visually excluding several smaller peaks from the integration.
Mass Spectrometry: Confirming Identity
Where HPLC tells you how clean a sample is, it does not by itself tell you what the main peak actually is. That's the role of mass spectrometry. MS ionizes the sample and measures the mass-to-charge ratio (m/z) of the resulting ions, which allows the instrument to calculate the molecular weight of the compound with high precision.
For peptides, the two most common ionization methods are Electrospray Ionization (ESI) and Matrix-Assisted Laser Desorption/Ionization (MALDI), both considered "soft" ionization techniques because they fragment the peptide minimally, preserving the intact molecule for an accurate mass reading. The observed molecular weight is then compared against the theoretical molecular weight calculated from the peptide's known amino acid sequence. A match within a small tolerance (commonly under 0.1–0.5%) confirms identity.
Some labs go a step further with tandem mass spectrometry (MS/MS), deliberately fragmenting the peptide and reading the resulting fragment masses to reconstruct the amino acid sequence directly — a more rigorous identity check than molecular weight matching alone, because two different sequences can occasionally share a similar overall mass.
Why Both Methods Are Needed
HPLC and MS are complementary, not interchangeable. A sample could show a single clean peak on HPLC — suggesting high purity — while that peak turns out, on MS, to be the wrong molecule entirely, or a close structural analog rather than the intended peptide. Conversely, MS can confirm that a given peak is the correct molecule without saying anything about how much of the total sample is impurities. A COA that reports only one of the two methods is reporting half the picture.
What to Look For in a Report
- An HPLC chromatogram image, not just a summary percentage — so the peak shape and any minor impurity peaks are visible.
- A stated column type and mobile phase (e.g., C18 reversed-phase, water/acetonitrile/TFA gradient), which signals the lab is reporting real method parameters rather than a generic template.
- A reported observed molecular weight compared against the theoretical molecular weight for the specific peptide and its exact sequence.
- The ionization method used (ESI or MALDI) and, ideally, the specific instrument model.
Sources
- U.S. Pharmacopeia (USP) General Chapter <621> Chromatography
- U.S. Pharmacopeia (USP) General Chapter <736> Mass Spectrometry
- International Council for Harmonisation (ICH) Q6B — Specifications for Biotechnological/Biological Products
- Journal of Chromatography B — peer-reviewed literature on peptide RP-HPLC method development
For research use only. Not for human or veterinary consumption.